Cancer Pain Market Set to Grow according to Forecasts with Key Players: Aoxing Pharmaceutical Company, BioDelivery Sciences International


Posted March 18, 2019 by srushtih

Increase in prevalence of cancer plays a major role in the growth of the global cancer pain market. Furthermore, higher number of unmet needs for management of cancer pain is expected to boost their demand in the coming years.

 
Increase in prevalence of cancer plays a major role in the growth of the global cancer pain market. Furthermore, higher number of unmet needs for management of cancer pain is expected to boost their demand in the coming years.

According to a new report published by Allied Market Research, titled,"Cancer Pain Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2018 - 2025,"the global cancer pain market was valued at $5,285 million in 2017, and is expected to reach $7,545 million by 2025, growing at a CAGR of 4.5% from 2018 to 2025.

North America accounted for more than one-third of the global market share in 2017 and is expected to remain dominant throughout the forecast period. This was attributed to the increase in demand for cancer pain therapeutics, high prevalence of cancer, wide availability of cancer pain drugs and trained medical professionals, and supportive reimbursement policies in the healthcare system. Asia-Pacific is expected to experience the highest growth rate during the forecast period majorly due to surge in incidence of cancer, with increase in adoption of cancer pain drugs for treatment of cancer.

Get Sample PDF Brochure of Cancer Pain Market at: https://www.alliedmarketresearch.com/request-sample/5123
Based on drug type, the global cancer pain market is categorized into opioids, non-opioids, and nerve blockers. The opioids segment was the major revenue contributor in 2017, and is anticipated to remain dominant during the forecast period due to increase in the adoption of opioids owing to rise in number of moderate to severe stage cancer patient population.

According to disease indication, the market is classified into lung cancer, colorectal cancer, breast cancer, prostate cancer, blood cancer, and others. The lung cancer segment presently dominates the market and is expected to remain dominant during the forecast period due to increase in adoption of cancer pain medication for the treatment and rise in prevalence of lung cancer, globally.

Cancer pain is chronic in nature and is commonly associated with cancer. It results from tissue damage, either due to the disease itself or due to different treatments such as chemotherapy, radiotherapy, or surgery. Cancer pain drugs are expected to exhibit significant market growth during the forecast period due to growth in demand for the drugs, surge in prevalence of cancer across the globe, increase in number of R&D activities to develop ideal cancer pain medications, and rise in the unmet needs for management of cancer pain.

Buy Now at: https://www.alliedmarketresearch.com/checkout/234864

Key Benefits for Cancer Pain Market:

• The study presents an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
• It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
• A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.
• The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Allied Market Research
Phone 9870715017
Business Address A-3 Building E space IT park
Country India
Categories Biotech , Health
Tags breast cancer , cancer pain market , colorectal cancer , lung cancer , prostate cancer
Last Updated March 18, 2019